XML 46 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Data (Unaudited)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Data [Abstract]  
Quarterly Financial Data (Unaudited) Quarterly Financial Data (Unaudited)
2020 Quarters
(in millions, except per share data)1st2nd3rd4th
Net revenues $6,359 $6,367 $7,123 $6,304 
Gross profit$2,873 $3,287 $3,717 $3,146 
Net earnings (losses)$1,550 $1,938 $(956)$1,922 
Net earnings (losses) attributable to Altria$1,552 $1,943 $(952)$1,924 
Per share data:
Basic and diluted earnings (losses) per share attributable to Altria$0.83 $1.04 $(0.51)$1.03 
2019 Quarters
(in millions, except per share data)1st2nd3rd
4th
Net revenues$5,628 $6,619 $6,856 $6,007 
Gross profit $2,811 $3,319 $3,497 $3,084 
Net earnings (losses)$1,121 $1,997 $(2,602)$(1,814)
Net earnings (losses) attributable to Altria$1,120 $1,996 $(2,600)$(1,809)
Per share data:
Basic earnings (losses) per share attributable to Altria$0.60 $1.07 $(1.39)$(0.97)
Diluted earnings (losses) per share attributable to Altria$0.60 $1.07 $(1.39)$(1.00)

During 2020 and 2019, the following pre-tax (gains) or charges were included in net earnings attributable to Altria:
 2020 Quarters
(in millions)1st2nd3rd4th
Impairment of JUUL equity securities$— $— $2,600 $— 
JUUL changes in fair value— — — (100)
Tobacco and health litigation items, including accrued interest24 18 34 7 
Asset impairment, exit, implementation and acquisition-related costs395 8 12 16 
ABI-related special items56 120 513 74 
Cronos-related special items89 (88)143 (93)
PMCC residual value adjustments— 34 — 91 
COVID-19 special items— 50 — — 
$564 $142 $3,302 $(5)
2019 Quarters
(in millions)1st2nd3rd
4th
Impairment of JUUL equity securities$— $— $4,500 $4,100 
Tobacco and health litigation items, including accrued interest17 28 3 29 
Asset impairment, exit, implementation and acquisition-related costs159 45 11 116 
ABI-related special items (1)
163 (129)(23)(394)
Cronos-related special items 425 119 549 (165)
$764 $63 $5,040 $3,686 
(1) Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments.

As discussed in Note 14. Income Taxes, Altria has recognized income tax benefits and charges in the consolidated statements of earnings (losses) during 2020 and 2019 as a result of various tax events.